ArticleAmerican journal of respiratory and critical care medicine2020
Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.
Nobuyuki Horita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.